Viking Therapeutics Stock Could Rocket 76% Higher According to Wall Street. Is It a Buy Now?
The new drugs this company is developing could be worth a lot more than the present market value of its stock.
| Ticker |
Sentiment |
Impact |
|
LLY
|
Neutral
|
10 %
|
|
MDGL
|
Neutral
|
5 %
|
|
VKTX
|
Somewhat Bullish
|
40 %
|
|
NVO
|
Neutral
|
5 %
|
